Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood and urinary concentrations of inhaled salmeterol in asthmatic subjects and elite athletes with asthma
2009-012069-70Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salmeterol in asthma (3 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoints: Serum concentrations of salmeterol and Urine concentrations of salmeterol. Started May 2009; status: completed.
02
Drugs
salmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-012069-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012069-70.